ConductScience.org, home

Paper25755548

Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India.

Puri P and 31 others. J Clin Exp Hepatol, 2014. Cited by 57 papers, by iCite.

Cite this record

ConductScience Library. Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India. Papers, record 25755548. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25755548

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India.
PubMed
Journal
J Clin Exp Hepatol
PubMed
Year
2014
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
57
iCite
Relative citation ratio, by iCite
2.13
iCite
Revised in PubMed
2024-10-03
PubMed

Authors32

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Puri PPankaj
2Anand ACAnil C
3Saraswat VAVivek A
4Acharya SKSubrat K
5Dhiman RKRadha K
6Aggarwal RRakesh
7Singh SPShivram P
8Amarapurkar DDeepak
9Arora AAnil
10Chhabra MMohinish
11Chetri KKamal
12Choudhuri GGourdas
13Dixit VKVinod K
14Duseja AAjay
15Jain AKAjay K
16Kapoorz DDharmesh
17Kar PPremashis
18Koshy AAbraham
19Kumar AAshish
20Madan KKaushal

Source PubMed

See all 32 authorsDownload CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References135

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19139079Magnitude of hepatitis C virus infection in India: prevalence in healthy blood donors, acute and chronic liver diseases.J Med Virol1997https://conductscience.org/library/papers/9139079PubMed
28840656Prevalence of anti-HCV antibodies in central India.Indian J Med Res1996https://conductscience.org/library/papers/8840656PubMed
319535750Prevalence of transfusion transmitted infections in blood donors: an Indian experience.Trop Doct2009https://conductscience.org/library/papers/19535750PubMed
41452308A study of hepatitis B and C prevalence and liver function in multiply transfused thalassemic and their parents.Indian Pediatr1992https://conductscience.org/library/papers/1452308PubMed
517883101Seroprevalence of hepatitis C antibodies in healthy blood donors--a prospective study.Indian J Pathol Microbiol2007https://conductscience.org/library/papers/17883101PubMed
618407613Occult hepatitis C virus infection is more common than hepatitis B infection in maintenance hemodialysis patients.World J Gastroenterol2008https://conductscience.org/library/papers/18407613PubMed
717934857Hepatitis-G virus infection in multi-transfused patients and intravenous drug abusers: New Delhi experience.Dig Dis Sci2008https://conductscience.org/library/papers/17934857PubMed
810063742Insignificant prevalence of antibodies to hepatitis C in a rural area of western Maharashtra.Indian J Gastroenterol1999https://conductscience.org/library/papers/10063742PubMed
912035351Comparison of seropositivity of HIV, HBV, HCV and syphilis in replacement and voluntary blood donors in western India.Indian J Pathol Microbiol2001https://conductscience.org/library/papers/12035351PubMed
1017659734Significant increase in HBV, HCV, HIV and syphilis infections among blood donors in West Bengal, Eastern India 2004-2005: exploratory screening reveals high frequency of occult HBV infection.World J Gastroenterol2007https://conductscience.org/library/papers/17659734PubMed
1122654292The current seroprevalence of hepatitis C virus in a tertiary care centre in vellore, Tamil Nadu.Indian J Community Med2012https://conductscience.org/library/papers/22654292PubMed
1218037715Prevalence & risk factors for hepatitis C virus among pregnant women.Indian J Med Res2007https://conductscience.org/library/papers/18037715PubMed
1311037680Transfusion transmitted diseases in haemophilics from western India.Indian J Med Res2000https://conductscience.org/library/papers/11037680PubMed
1418845962High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern.J Acquir Immune Defic Syndr2008https://conductscience.org/library/papers/18845962PubMed
1511225211Hepatitis C virus infection during haemodialysis in India.J Assoc Physicians India1999https://conductscience.org/library/papers/11225211PubMed
1621651703A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt.Liver Int2011https://conductscience.org/library/papers/21651703PubMed
178270554Antibody to hepatitis-C virus in multi-transfused thalassaemics--Indian experience.J Assoc Physicians India1993https://conductscience.org/library/papers/8270554PubMed
1815564751Prevalence of hepatitis B and hepatitis C viral infections in Indian patients with chronic renal failure.Intervirology2004https://conductscience.org/library/papers/15564751PubMed
1915064522Transfusion associated hepatitis C in multi-transfused thalassemic children.Indian Pediatr2004https://conductscience.org/library/papers/15064522PubMed
2018436948GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.BMJ2008https://conductscience.org/library/papers/18436948PubMed

See all 135 referencesDownload CSV of references

Cited by43

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 57 citations.

PMIDTitleJournalYearIn PapersSource
41023889Assessment of direct-acting antiviral treatment outcomes in patients with chronic hepatitis C infected with various HCV genotypes: Insights from a real-world cohort in West Bengal, India.BMC Infect Dis2025https://conductscience.org/library/papers/41023889PubMed
40575638Micro RNAs as a potential biomarker for predicting liver fibrosis severity in hepatitis C virus affected patients.World J Virol2025https://conductscience.org/library/papers/40575638PubMed
40166523Sustained Virological Response After Direct-Acting Antiviral Therapy in Hepatitis C Virus-Infected Individuals With and Without Decompensated Liver Cirrhosis: A One-Year Follow-Up Study.Cureus2025https://conductscience.org/library/papers/40166523PubMed
38558861The Fixed Dose Combination of Sofosbuvir and Velpatasvir is Safe and Effective in Patients of Chronic Hepatitis C With End-stage Renal Disease.J Clin Exp Hepatol2024https://conductscience.org/library/papers/38558861PubMed
38358146Assessment of factors affecting response of direct-acting antivirals in chronic hepatitis C patients.Ann Afr Med2023https://conductscience.org/library/papers/38358146PubMed
37908870Safety and efficacy of treatment for chronic hepatitis C during pregnancy: A prospective observational study in Srinagar, India.Clin Liver Dis (Hoboken)2023https://conductscience.org/library/papers/37908870PubMed
36935711The burden of hepatitis C virus in the world, China, India, and the United States from 1990 to 2019.Front Public Health2023https://conductscience.org/library/papers/36935711PubMed
34367809Hepatitis C Viral Infection Among Beta-Thalassemia Patients: A Study From the Centre for Excellence in Thalassemia and Other Blood Disorders.Cureus2021https://conductscience.org/library/papers/34367809PubMed
33679045Comparison of Elastography Point Quantification with Transient Elastography in Patients with Chronic Viral Hepatitis and Nonalcoholic Fatty Liver Disease: A Pilot Study.J Clin Exp Hepatol2021https://conductscience.org/library/papers/33679045PubMed
33589457Cost-effectiveness and budget impact analysis of facility-based screening and treatment of hepatitis C in Punjab state of India.BMJ Open2021https://conductscience.org/library/papers/33589457PubMed
33312979Seropositivity Load in Orthopedic Surgery at Tertiary Care Hospitals in North India - An Observational Study.J Orthop Case Rep2020https://conductscience.org/library/papers/33312979PubMed
32655234Incidence and Risk Factors for Hepatitis C Virus and Hepatitis B Virus Seroconversion in End-Stage Renal Failure Patients on Maintenance Hemodialysis.J Clin Exp Hepatol2020https://conductscience.org/library/papers/32655234PubMed
32405174Sofosbuvir-Velpatasvir Fixed Drug Combination for the Treatment of Chronic Hepatitis C Infection in Patients With End-Stage Renal Disease and Kidney Transplantation.J Clin Exp Hepatol2020https://conductscience.org/library/papers/32405174PubMed
32189931Genotype 1 and 3 Response to Velpatasvir and Sofosbuvir in Chronic Hepatitis C in the Kashmiri Population: An Observational Study.J Clin Exp Hepatol2020https://conductscience.org/library/papers/32189931PubMed
31852635Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.Lancet Gastroenterol Hepatol2020https://conductscience.org/library/papers/31852635PubMed
31465503
Real-world cost-effectiveness of pan-genotypic Sofosbuvir-Velpatasvir combination versus genotype dependent directly acting anti-viral drugs for treatment of hepatitis C patients in the universal coverage scheme of Punjab state in India.
PLoS One2019https://conductscience.org/library/papers/31465503PubMed
31360030Indian National Association for the Study of the Liver-Federation of Obstetric and Gynaecological Societies of India Position Statement on Management of Liver Diseases in Pregnancy.J Clin Exp Hepatol2019https://conductscience.org/library/papers/31360030PubMed
31170246Cost-effectiveness and budgetary impact of HCV treatment with direct-acting antivirals in India including the risk of reinfection.PLoS One2019https://conductscience.org/library/papers/31170246PubMed
30903612Genotype distribution in relation to viral load in a large cohort of Indian patients with chronic hepatitis C virus infection: A retrospective analysis.Indian J Gastroenterol2019https://conductscience.org/library/papers/30903612PubMed
30790229Sofosbuvir-velpatasvir single-tablet regimen administered for 12 weeks in a phase 3 study with minimal monitoring in India.Hepatol Int2019https://conductscience.org/library/papers/30790229PubMed

See all 43 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25755548

GET https://conductscience.org/api/papers/v1/25755548/authors?page=2